STERIS plc Delivers Strong Q4 Revenue, EPS Growth
STERIS plc reported Q4 revenue of $1.60B, beating estimates, and adjusted EPS of $2.83, slightly below expectations. The company also announced a $60M Ohio plant expansion and $1B share buyback program.
STERIS plc's Q4 results show strong revenue growth at $1.60B, surpassing the factSet estimate of $1.59B. This, however, was offset by slightly lower adjusted earnings per share (EPS) of $2.83, which came in below the estimate of $2.85.
Despite the EPS miss, the company's stock price rose following the earnings release, driven by the strong revenue growth and positive outlook. This indicates investor confidence in STERIS' performance, particularly given the growth across multiple segments.
STERIS is also investing in expansion, with a notable $60M commitment for a new Ohio plant, expected to support its growing operations. Additionally, the company has launched a substantial $1B share buyback program, underscoring its confidence in its financial position.
Related Stocks
Powered by SentiSense - Intelligent Market Analysis